Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Sanofi SA (SASY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
86.650 +1.220    +1.43%
- Closed. Currency in EUR ( Disclaimer )
  • Volume: 4,462
  • Bid/Ask: 85.020 / 86.740
  • Day's Range: 85.150 - 86.960
Type:  Equity
Market:  Germany
ISIN:  FR0000120578 
WKN:  920657
Sanofi 86.650 +1.220 +1.43%

SASY Share Price Overview

 
Find here information about Sanofi share price. You can find more details about Sanofi shares by going to one of the sections listed on this page such as historical data, price charts, Sanofi stock price technical analysis and more.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close85.43
Day's Range85.15 - 86.96
Revenue46.03B
Open85.15
52 wk Range80.8 - 105.14
EPS4.31
Volume4,462
Market Cap108.71B
Dividend (Yield)3.76 (4.4%)
Average Volume (3m)3,410
P/E Ratio11.96
Beta0.444
1-Year Change - 15.93%
Shares Outstanding1,248,557,653
Next Earnings DateApr 25, 2024
What is your sentiment on Sanofi?
or
Market is currently closed. Voting is open during market hours.

Sanofi SA News Today


Founder of scandal-hit drugmaker Servier dies at 92
Founder of scandal-hit drugmaker Servier dies at 92 By Reuters - Apr 17, 2014

PARIS (Reuters) - Jacques Servier, founder and president of France's second-largest drugmaker, has died before his trial over Mediator, a weight-loss pill at the centre of the...

Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Buy Sell Sell
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Sell Strong Sell
Summary Strong Buy Strong Buy Strong Buy Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Shooting Star 30 Current
Bullish Engulfing 1D Current
Completed Patterns
Deliberation Bearish 1H 4 Apr 19, 2024 11:00
Doji Star Bearish 1H 4 Apr 19, 2024 11:00
Three Outside Down 1M 5 Nov 23

Sanofi SA Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Paris 86.89 0.00 0.00 1,871,390 +1.95% EUR 16:35:00  
  BATS Europe 86.76 85.67 0.00 3,607 +1.69% EUR 16:09:25  
  NASDAQ 46.49 0.00 0.00 2,489,022 +2.42% USD 19:22:38  
  London 86.61 84.99 87.87 832,530 +1.70% EUR 16:35:59  
  Mexico 795.00 810.00 862.00 0 0.00% MXN 02/04  
  Milan 86.70 0.00 0.00 323 +1.76% EUR 16:06:51  
  TradeGate 87.53 87.42 87.52 5,055 +2.19% EUR 19:05:57  
  Frankfurt 85.96 87.15 87.63 1,555 +0.24% EUR 14:37:33  
  Xetra 86.650 85.020 86.740 4,462 +1.43% EUR  
  Vienna 86.80 86.65 86.78 0 +0.00% EUR 17/04  

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  IAG 169.50 170.10 162.15 -0.30 -0.18% 27.55M 16:35:59  
  Rolls-Royce Holdings 395.50 399.00 391.20 -7.00 -1.74% 40.91M 16:35:59  
  Barclays 185.84 185.90 181.50 +1.86 +1.01% 55.13M 16:35:59  
  Lloyds Banking 50.92 51.08 50.20 -0.08 -0.16% 115.16M 16:35:59  
  Avacta Group 48.50 48.50 46.28 +0.50 +1.04% 2.98M 16:35:59  
  EasyJet 535.20 536.00 514.57 +5.20 +0.98% 3.30M 16:35:59  
  Helium One 1.3780 1.4825 1.2500 +0.1030 +8.08% 69.85M 16:35:59  
  HSBC 646.20 647.60 633.80 +1.60 +0.25% 40.81M 16:35:59  
  BP 514.90 516.01 504.60 +2.50 +0.49% 42.63M 16:35:59  
  Vodafone Group PLC 67.000 67.100 65.780 +0.620 +0.93% 58.54M 16:35:59  

%SHORT_NAME% Company Profile

IndustryPharmaceuticals
SectorHealthcare
Employees

91573

Equity Type

ORD

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SASY Price Commentary

Write your thoughts about Sanofi SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Boubacar s b Toure
Boubacar s b Toure Mar 11, 2023 1:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nzf
Oct 06, 2022 18:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will eventually do well because of French strategy. France is at the top table and Sanofi was made up by absorbing others to grow. Look at 20% in a couple of years
Greg Greg
Greg Greg Dec 11, 2020 9:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
there is no future for it
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email